Author:
Tsilimigras Diamantis I.,Bagante Fabio,Moris Dimitrios,Hyer J. Madison,Sahara Kota,Paredes Anghela Z.,Mehta Rittal,Ratti Francesca,Marques Hugo P.,Soubrane Olivier,Lam Vincent,Poultsides George A.,Popescu Irinel,Alexandrescu Sorin,Martel Guillaume,Workneh Aklile,Guglielmi Alfredo,Hugh Tom,Aldrighetti Luca,Endo Itaru,Pawlik Timothy M.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Beal EW, Tumin D, Kabir A, et al. Trends in the mortality of hepatocellular carcinoma in the United States. J Gastrointest Surg. 2017; 21(12): 2033–8.
2. Lafaro KJ, Demirjian AN, Pawlik TM. Epidemiology of hepatocellular carcinoma. Surg Oncol Clin N Am. 2015; 24(1): 1–17.
3. Vietti Violi N, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018; 3(5): 317–25.
4. European Association for the Study of the Liver. Electronic address eee, European Association for the study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018; 69(1): 182–236.
5. Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018; 68(2): 723–50.
Cited by
77 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献